Showing results (281-290 of 669) with videos related to
Sort By:
Pageof 67
Human Molecular Genetics|January 15, 2005
Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish populationAvraham Shaag, Tom Walsh, Paul Renbaum, et al.Annals of Surgical Oncology|June 29, 2007
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesisTari A King, Weiwei Li, Edi Brogi, et al.Canadian Family Physician Medecin De Famille Canadien|June 15, 2021
Newborn screening for cystic fibrosis: Role of primary care providers in caring for infants with positive screening resultsJune C Carroll, Robin Z Hayeems, Fiona A Miller, et al.JCO Precision Oncology|December 12, 2024
Clinical Utility of Genomic Sequencing for Hereditary Cancer Syndromes: An Observational Cohort StudySalma Shickh, Chloe Mighton, Marc Clausen, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 9, 2016
A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosisYvonne Bombard, Fiona A Miller, Carolyn J Barg, et al.Journal of Medical Genetics|September 21, 2021
A step forward, but still inadequate: Australian health professionals' views on the genetics and life insurance moratoriumJane M Tiller, Louise A Keogh, Aideen M McInerney-Leo, et al.JAMA Internal Medicine|August 18, 2016
Physician-Driven Variation in Nonrecommended Services Among Older Adults Diagnosed With CancerAllison Lipitz-Snyderman, Camelia S Sima, Coral L Atoria, et al.Breast Cancer Research and Treatment|November 3, 2016
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer familyCiyu Yang, Angela G Arnold, Magan Trottier, et al.Journal of the National Cancer Institute|September 22, 2005
Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer familiesNoah D Kauff, Nandita Mitra, Mark E Robson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex TestingJudith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.Pageof 67